Abstract
CME Exam 2: Abnormal TP53 Predicts Risk of Progression in Patients With Barrett’s Esophagus Regardless of a Diagnosis of Dysplasia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1053/j.gastro.2021.12.231
Journal: Gastroenterology | Publication Date: Dec 9, 2021 |
CME Exam 2: Abnormal TP53 Predicts Risk of Progression in Patients With Barrett’s Esophagus Regardless of a Diagnosis of Dysplasia
Join us for a 30 min session where you can share your feedback and ask us any queries you have